Further analysis of these differential sites revealed the increased enrichment of motifs for other ETS TFs such as FLI1, ELK4 and ELK1 (Fig. 1e), which have been implicated in cancer progression, following TWEAK-induced p52 activation22–24. The gene discussed is ELK1; the disease is cancer.